Moderna and Merck announced on August 19 that their mRNA-based cancer vaccine significantly extended disease-free survival in melanoma patients compared to Keytruda alone in a late-stage trial. Moderna's stock surged 100% following the announcement.
No BS check run yet — press ⚖ to extract this story's claims and verify them against independent sources.
The combination regimen significantly extended the time patients lived without their melanoma returning, compared with Keytruda alone.
Moderna, Merck cancer vaccine shows promise in late-stage phase three trial L: https://www. cnbc.com/2026/08/19/moderna-me rck-cancer-vaccine-shows-initial-late-stage-melanoma-data.html C: https:// news.ycombinator.com/item?id=4 9360936 posted on 2026.08.19 at 08:53:22 (c=1, p=7)
Moderna and Merck say mRNA cancer vaccine succeeded in late-stage melanoma trial L: https://www. statnews.com/2026/08/19/mrna-c ancer-vaccine-trial-melanoma-merck-moderna/ C: https:// news.ycombinator.com/item?id=4 9361309 posted on 2026.08.19 at 09:23:54 (c=0, p=8)
Woah!!!! This is huge news. www.bostonglobe.com/2026/08/19/b... Results could herald a new, powerful approach in other cancers.
www.cnbc.com/2026/08/19/m... The combination regimen significantly extended the time patients lived without their melanoma returning, compared with Keytruda alone.
this outlet adds: initial, data, share, google, zk2sldapiz9o
Moderna cofounder Bob Langer is a billionaire again, as share prices have nearly doubled on the news of the success of the company's latest cancer vaccine. www.forbes.com/sites/tylerr... The biotech giant announced favorable results from a late-stage trial of a cancer vaccine.
Moderna stock more than doubles after melanoma vaccine trial shows "landmark moment" - CBS News https://www. cbsnews.com/news/moderna-stock -melanoma-cancer-vaccine/ Trial shows vaccine keeping skin cancer from returning or spreading.
abc7news.com/post/persona... Merck and Moderna announced Wednesday that a personalized mRNA-based cancer vaccine succeeded in a large, late-stage trial among high-risk patients with melanoma.
Today's news: Moderna and Merck say mRNA cancer vaccine succeeded in late-stage melanoma trial www.statnews.com/2026/08/19/m... A personalized mRNA cancer vaccine succeeded in a late-stage melanoma study, results that could herald a new, powerful approach in oncology.
this outlet adds: stunning, many, advances, happened, care, last, decade, coming
I'm assuming all the MAGA types will opt out of this one? Right? Right....? www.cnbc.com/2026/08/19/m... The combination regimen significantly extended the time patients lived without their melanoma returning, compared with Keytruda alone.
this outlet adds: good, news, personalized, could, eventually, work, across, multiple
this outlet adds: announced, breakthrough, trials, jointly, developed, personalized, yesterday, giving
The vaccine is built on the mRNA platform that allowed Moderna to quickly roll out COVID-19 vaccines five years ago.
"A personalized mRNA cancer vaccine, added to an existing treatment, slowed the return of melanoma and its spread to other parts of the body in a late-stage clinical trial, the drugmakers Merck and Moderna announced Wednesday, results that could herald a new, powerful approach in oncology." The drugmakers did not immediately release detailed data. Moderna stock price rose 174% today! 😮 https://ww
First mRNA Cancer Vaccine Succeeds in Late-Stage Trial, Moderna Stock Soars A personalized mRNA vaccine that trains the immune system to fight each patient's specific tumor just became the first of its kind to succeed in a Phase 3 trial, sending Moderna to its best trading day since going public in 2018.
Moderna’s cancer vaccine results doubled its stock price after taxpayers paid to help develop it. www.levernews.com/money-shot/?... Moderna’s cancer vaccine results doubled its stock price after taxpayers paid to help develop the treatment.